Dermot Moynagh

Dermot Moynagh is an experienced professional in global market access and pricing strategy, currently serving as the Pricing & Access Strategy Lead for Immunology at Bristol-Myers Squibb since September 2018, focusing on tyrosine kinase inhibitor indications. Prior roles include Director of Global Market Access Strategy at Pfizer, where Dermot led the market access efforts for a diabetes alliance with Merck and managed established cardiovascular portfolios, among other strategic initiatives. Additional experience includes project management at Wyeth Pharmaceuticals, where outstanding leadership earned Dermot the Above and Beyond Award, and research in chemistry at Hoffmann-La Roche. Dermot holds an MBA in Pharmaceutical Marketing from Saint Joseph's University and multiple degrees in chemistry and science from Trinity College Dublin and University College Dublin.